PER percheron therapeutics limited

Ann: Phase IIb study of ATL1102 in DMD completes recruitment, page-158

  1. 99 Posts.
    lightbulb Created with Sketch. 30
    I think it's also comforting to see that the worst score with 1102 is still better than the worst score without it on every measure, so you could say there are no statistical outliers. Movitplate is the exception in those results which Garner himself said nobody really knows why and is "of uncertain significance in DMD". Overall there's consistency in the results. My favourite comment from Garner in his AGM presentation last year was about some of the results from the strength tests being subjective but an MRI is objective and therefore positive results in an MRI scan of muscles are hard to dispute.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.0¢
Change
0.000(0.00%)
Mkt cap ! $10.87M
Open High Low Value Volume
1.0¢ 1.0¢ 1.0¢ $7.665K 766.5K

Buyers (Bids)

No. Vol. Price($)
1 3790595 1.0¢
 

Sellers (Offers)

Price($) Vol. No.
1.1¢ 3172198 6
View Market Depth
Last trade - 12.55pm 24/06/2025 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.